Literature DB >> 10537252

Indomethacin for 3 days is not effective as prophylaxis for heterotopic ossification after primary total hip arthroplasty.

H J van der Heide1, R T Koorevaar, B W Schreurs, A van Kampen, A Lemmens.   

Abstract

Although indomethacin is effective in preventing heterotopic ossification (HO) after total hip arthroplasty (THA) when used for 8 to 14 days, side effects are frequently observed. We conducted a prospective, nonrandomized pilot study of prophylaxis for HO in THA using indomethacin for 3 days. We used a 2-stage design for phase 2 clinical data, based on earlier studies in our department. Our study group consisted of 19 patients, of whom 14 (74%) developed HO; 7 (37%) showed grade 1, 4 (21%) grade II, and 3 (15.8%) grade III according to the Brooker classification. We compared these results with 2 historic control groups; one group received indomethacin for 7 days, and the other group received no prophylaxis. We did not see any reduction of the ossification relative to the group that received no prophylaxis. Indomethacin for 3 days seems not to be sufficient to prevent HO.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10537252     DOI: 10.1016/s0883-5403(99)90027-x

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  4 in total

Review 1.  Prevention of heterotopic ossification after total hip replacement with NSAIDs.

Authors:  Roel Fijn; Rinco Th Koorevaar; Jacobus R Brouwers
Journal:  Pharm World Sci       Date:  2003-08

2.  Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials.

Authors:  Deting Xue; Qiang Zheng; Hang Li; Shengjun Qian; Bo Zhang; Zhijun Pan
Journal:  Int Orthop       Date:  2009-10-15       Impact factor: 3.075

3.  The efficacy of a multimodal analgesia protocol in preventing heterotopic ossification after acetabular fractures surgery.

Authors:  Liang Cheng; Hai-Tao Long; Bu-Hua Sun; Shu-Shan Zhao; Yong Zhu
Journal:  Int J Clin Pharm       Date:  2017-05-12

4.  Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?

Authors:  Jaap J Brunnekreef; Paul Hoogervorst; Marieke J Ploegmakers; Wim H Rijnen; Berend W Schreurs
Journal:  Int Orthop       Date:  2013-01-29       Impact factor: 3.075

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.